Nearly 3 years after passage of the Physician Payments Sunshine Act, the Centers for Medicare & Medicaid Services (CMS) released its final rule intended to increase public awareness of financial relationships between drug and device manufacturers and certain health care practitioners.
© 2001-2026 Fundación Dialnet · Todos los derechos reservados